rethinkPeptides Search
Menu
Study breakdown

Vitamin A Derivative Made Pituitary Cells More Responsive to Growth Hormone-Releasing Peptides GHRH and Ghrelin

evidence
The takeaway

Retinoic acid selectively increased the receptors for GHRH and ghrelin in pituitary cells, amplifying growth hormone release in response to these peptide signals without affecting baseline secretion.

Selective upregulation

retinoic acid increased GHRH and ghrelin receptors but not somatostatin receptors — amplifying stimulatory peptide signals while leaving inhibitory control intact

What the researchers found

Retinoic acid (ATRA) upregulated gene expression of both GHRH receptor and ghrelin receptor (GHS-R) in rat pituitary cells, but did not change somatostatin receptor expression. This selectively enhanced the pituitary's responsiveness to the stimulatory peptides GHRH and ghrelin while leaving the inhibitory somatostatin pathway unchanged. ATRA amplified GHRH- and ghrelin-stimulated growth hormone release without affecting basal secretion. Effects were mediated through the RAR-RXR nuclear receptor complex.

Why it matters

This reveals a new layer of regulation for growth hormone release: vitamin A (retinoic acid) selectively tunes the pituitary's sensitivity to peptide hormones GHRH and ghrelin. Understanding this mechanism could inform approaches to growth disorders, aging-related GH decline, and conditions where GHRH/ghrelin signaling is impaired.

The numbers in context

ATRA 10⁻⁶ M · 24h treatment · increased Ghrh-r and Ghs-r mRNA · Sst-r2 and Sst-r5 unchanged · enhanced GHRH- and ghrelin-stimulated GH release · basal GH unaffected

How the study worked

Anterior pituitary cells isolated from male Wistar rats were cultured and treated with ATRA (10⁻⁶ M) for 24 hours. Receptor gene expression was measured by quantitative real-time PCR. Growth hormone release was assessed under basal and stimulated (GHRH, ghrelin) conditions. RAR-agonist (Am80) and RXR-agonist (PA024) were tested to confirm receptor pathway involvement.

Who was studied

Isolated anterior pituitary cells from male Wistar rats (in vitro)

What this study cannot tell us

In vitro study using isolated rat pituitary cells — the in vivo regulatory context (hypothalamic input, feedback loops) is absent. Only one concentration of ATRA and one time point were tested. Human pituitary cells may respond differently. The functional significance of the receptor upregulation for whole-organism GH physiology was not assessed.

How to read the evidence

This is a basic science in vitro study using isolated rat pituitary cells with appropriate controls (RAR/RXR agonist confirmation). It provides clear mechanistic data but represents early-stage evidence without in vivo validation or human relevance confirmation.

When this study was published

Published in 2016, this study contributes to understanding how nutritional factors regulate peptide hormone receptor expression, a topic with ongoing relevance to endocrinology and peptide therapeutics.

The bigger picture

Growth hormone secretion is tightly controlled by a balance between stimulatory peptides (GHRH, ghrelin) and inhibitory ones (somatostatin). Finding that retinoic acid selectively tips this balance toward stimulation adds nutritional status (vitamin A) to the list of factors regulating GH physiology. This has implications for understanding growth disorders in vitamin A-deficient populations and could inform combinatorial approaches to enhancing GH release in clinical settings.

Questions still open

  • Does vitamin A deficiency impair growth hormone release through reduced GHRH/ghrelin receptor expression in the pituitary?
  • Could retinoic acid be combined with GHRH or ghrelin analogs to enhance their therapeutic effect in growth hormone deficiency?
  • Do these receptor expression changes translate to altered GH secretion patterns in vivo?

Common questions

What are GHRH and ghrelin, and how do they relate to growth hormone?
GHRH (growth hormone-releasing hormone) and ghrelin are two peptide hormones that stimulate the pituitary gland to release growth hormone. GHRH comes from the brain's hypothalamus, while ghrelin comes mainly from the stomach. Both are essential for normal growth hormone secretion, and synthetic versions of both are used medically.
Why does it matter that somatostatin receptors weren't affected?
Somatostatin is the 'brake' on growth hormone release. If retinoic acid had also reduced somatostatin receptors, it could cause uncontrolled GH release, which would be problematic. Instead, retinoic acid only increased the 'accelerator' receptors (GHRH-R and GHS-R), creating a more nuanced enhancement that preserves the body's safety checks on growth hormone secretion.

Read the original research

Effects of retinoic acid on growth hormone-releasing hormone receptor, growth hormone secretagogue receptor gene expression and growth hormone secretion in rat anterior pituitary cells.

Endocrine journal, 63(6), 555-61

Citation

Maliza, Rita; Fujiwara, Ken; Tsukada, Takehiro; Azuma, Morio; Kikuchi, Motoshi; Yashiro, Takashi. (2016). Effects of retinoic acid on growth hormone-releasing hormone receptor, growth hormone secretagogue receptor gene expression and growth hormone secretion in rat anterior pituitary cells.. Endocrine journal, 63(6), 555-61. https://doi.org/10.1507/endocrj.EJ16-0086